Production (Stage)
Bio-Techne Corporation
TECH
$46.78
-$0.54-1.14%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 4.20% | 8.96% | 4.52% | 1.59% | 3.16% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.20% | 8.96% | 4.52% | 1.59% | 3.16% |
| Cost of Revenue | 3.15% | 5.93% | 10.69% | 8.04% | 6.54% |
| Gross Profit | 4.71% | 10.58% | 1.47% | -1.46% | 1.62% |
| SG&A Expenses | 38.75% | 12.32% | 4.02% | 11.45% | 7.04% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 17.37% | 9.29% | 6.27% | 8.97% | 7.50% |
| Operating Income | -38.10% | 7.48% | -2.69% | -17.69% | -8.69% |
| Income Before Tax | -37.34% | 28.42% | -18.94% | -52.83% | -23.83% |
| Income Tax Expenses | 30.44% | 34.85% | 557.91% | -91.64% | 20.52% |
| Earnings from Continuing Operations | -53.96% | 27.03% | -34.11% | -46.23% | -30.13% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -53.96% | 27.03% | -34.11% | -46.23% | -30.13% |
| EBIT | -38.10% | 7.48% | -2.69% | -17.69% | -8.69% |
| EBITDA | -27.36% | 3.84% | -2.25% | -12.35% | -6.16% |
| EPS Basic | -53.98% | 26.33% | -34.27% | -46.36% | -30.14% |
| Normalized Basic EPS | -33.17% | 7.82% | 10.95% | -17.50% | -15.67% |
| EPS Diluted | -54.84% | 29.41% | -32.26% | -44.19% | -27.91% |
| Normalized Diluted EPS | -32.52% | 8.06% | 11.81% | -16.64% | -15.08% |
| Average Basic Shares Outstanding | 0.04% | 0.57% | 0.25% | 0.23% | 0.00% |
| Average Diluted Shares Outstanding | -0.97% | 0.35% | -0.51% | -0.78% | -0.69% |
| Dividend Per Share | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Payout Ratio | 1.17% | -0.20% | 0.52% | 0.86% | 0.43% |